CALGARY, Nov. 7, 2013 /CNW/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) (“Oncolytics” or the “Company”) today announced its financial results and operational highlights for the quarter ended September 30, 2013.
“In recent months we have reported positive data in our squamous cell and non-squamous cell lung clinical trials both in terms of tumour response and survival,” said Dr. Brad Thompson, President and CEO of Oncolytics.
Help employers find you! Check out all the jobs and post your resume.
